Thus, this fluoroalkylketone intended for neuroimaging, could be of interest in palliative therapy of Alzheimer’s disease and protection of central AChE against organophosphorus compounds. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.